Recent Advances in Immunomodulatory Therapy in Sepsis: A Comprehensive Review.
| Autor: | Jain A; Critical Care Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND., Singam A; Critical Care Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND., Mudiganti VNKS; Critical Care Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2024 Mar 31; Vol. 16 (3), pp. e57309. Date of Electronic Publication: 2024 Mar 31 (Print Publication: 2024). |
| DOI: | 10.7759/cureus.57309 |
| Abstrakt: | Sepsis remains a critical healthcare challenge, characterized by dysregulated immune responses to infection, leading to organ dysfunction and high mortality rates. Traditional treatment strategies often fail to address the underlying immune dysregulation, necessitating exploring novel therapeutic approaches. Immunomodulatory therapy holds promise in sepsis management by restoring immune balance and mitigating excessive inflammation. This comprehensive review examines the pathophysiology of sepsis, current challenges in treatment, and recent advancements in immunomodulatory agents, including biologics, immunotherapy, and cellular therapies. Clinical trial outcomes, safety profiles, and future research and clinical practice implications are discussed. While immunomodulatory therapies show considerable potential in improving sepsis outcomes, their successful implementation requires further research, collaboration, and integration into standard clinical protocols. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2024, Jain et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|